4//SEC Filing
Prasad Raju 4
Accession 0000950170-24-035516
CIK 0001674416other
Filed
Mar 21, 8:00 PM ET
Accepted
Mar 22, 5:45 PM ET
Size
7.8 KB
Accession
0000950170-24-035516
Insider Transaction Report
Form 4
Prasad Raju
Chief Financial Officer
Transactions
- Award
Stock Option (Right to Buy)
2024-03-20+36,168→ 36,168 totalExercise: $72.94Exp: 2034-03-20→ Common Shares (36,168 underlying) - Award
Restricted Stock Units
2024-03-20+25,000→ 25,000 total→ Common Shares (25,000 underlying)
Footnotes (3)
- [F1]This option was granted on March 20, 2024 with respect to 36,168 Common Shares. 100% of the shares will vest in 48 equal monthly installments, with the first vesting date of April 20, 2024.
- [F2]Each restricted stock unit represents a contingent right to receive one share of CRSP Common Shares.
- [F3]This restricted stock unit award was granted on March 20, 2024 with respect to 25,000 Common Shares, with (i) one quarter of the shares vesting on March 20, 2025, (ii) one quarter of the shares vesting on March 20, 2026, (iii) one quarter of the shares vesting on March 20, 2027, and (iv) one quarter of the shares vesting on March 20, 2028.
Documents
Issuer
CRISPR Therapeutics AG
CIK 0001674416
Entity typeother
Related Parties
1- filerCIK 0001968317
Filing Metadata
- Form type
- 4
- Filed
- Mar 21, 8:00 PM ET
- Accepted
- Mar 22, 5:45 PM ET
- Size
- 7.8 KB